# IRulya Therapeutics Inc.: Form 8-K, filed Jan 29, 2026

- Company: [IRulya Therapeutics Inc.](/companies/irla.md) (CIK 1662774)
- Form: 8-K
- Filed: 2026-01-29
- Accepted by EDGAR: Jan 29, 2026, 16:40 ET
- Period: 2026-01-29
- Accession: 0001193125-26-029524
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1662774/000119312526029524/d61547d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662774/000119312526029524/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662774/000119312526029524/d61547d8k.htm

Filed Jan 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-029524. Last ingested by Listed: Nov 15, 2026, 02:27 ET. No prices; not investment advice.
